Legal Issues Raised
by Profitable Biotechnology Development Through Marine Scientific
Research
By Montserrat Gorina-Ysern
September 2003
In July 2003, the Secretary of State for Environment,
Food and Rural Affairs of the United Kingdom invited
proposals for a "Study into the Legal and Moral
Framework for Marine Biotechnology Development in
the UK." The study, when complete, should constitute
a pioneering effort to deal with a growing and important
field of international law that is poorly understood
and researched but that is gaining considerable
significance in practice, and poses complex legal,
moral and environmental issues.
[1]
The international law of the sea has not kept
pace with the development of profitable application
of biotechnology,
[2] or with pharmaceutical and marine biomedical
research relating to marine biota. As a result,
there is a very limited understanding of the relationships
between different legal instruments dealing with
ownership of marine data, samples and results,
and the principles regulating the allocation of
legal title to products and processes deriving
from such applications, or about the environmental
and moral consequences of such uses. Studies on
biotechnology applications focus on three main
industries: agriculture,
[3] pharmaceutical, [4] and shipping, [5]
even though marine biotechnology is a growing
field. Marine biotechnology has been applied to
aquaculture and seafood supply enhancement, to
the commercial and industrial production of marine
substances and processes such as antibio-fouling
agents and adhesives for the shipping and maritime
industries, and for the navies of industrialized
States; it has yielded marine pharmaceuticals,
cosmetics and biomedical applications, and it
has improved environmental monitoring and resource
management. [6]
The potential market revenue for these industrial
uses has conservatively been assessed at US$3
billion per year.
[7] Another estimate puts world-wide sales
of marine biotech related products at $100 billion
in the year 2000. [8] These estimates indicate the potential royalty
and other monetary returns that university researchers
may receive as a result of patenting and licensing
innovations to private industry. Current literature,
however, fails to estimate the potential financial
returns for coastal States of origin of the marine
biogenetic resources used in tests and cell cultures
driving the bonanza of commercialized marine resource-related
inventions.
What is MSR?
Marine Scientific Research (MSR) is a term applied
to a range of scientific disciplines (such as
physics, biology, chemistry, geology, geophysics)
concerned with the study of the ocean, its biota
and its physical boundaries with the solid earth
and the atmosphere. [9] The conduct of MSR activities is regulated in Part XIII, 1982
UNCLOS and other rules of international law. In
essence, MSR is a freedom of the high seas beyond
the limits of a coastal nations' jurisdiction
(usually beyond the 200 nautical mile boundary
measured from the low water mark). MSR activities
conducted within the 200 nautical mile boundary
of another nation are subject to the prior consent
of that nation, and require the researching State
to comply with a range of obligations toward the
host nation, including a duty to share data, samples
and results obtained, and to permit the participation
of the host nation's observers or participants
on board the foreign vessel. In practice, the
extent of international law regulation over MSR
activities can be described as cumbersome but
successful.
However, the current international regime for
MSR under UNCLOS does not deal with proprietary
title over MSR data, samples and results. The
vast majority of MSR projects do not directly
bear on the exploration or exploitation of natural
resources, but on fundamental oceanographic research.
The results are openly disseminated through regional
and international exchange systems. By contrast,
a growing field of MSR activities, not directly
bearing on the exploration or exploitation of
natural resources, may yield data, samples and
results leading to the potential commercialization
of marine products or processes protected under
Intellectual Property Rights regimes (IPRs). These
property rights determine who owns the product
of the human intellect that has commercial value
and what rights the law is prepared to protect
on the basis of such ownership. The extent of
protection varies across national systems. International
protection is dependent upon interested states'
membership in international IPR treaties. International
law has not dealt with these interrelated issues
adequately.
Integrating MSR Regulation under UNCLOS with
Other International Law Regimes
Access to MSR data and samples in foreign coastal
areas is regulated under the 1982 UNCLOS and under
coastal State domestic legislation. The export
of certain samples from coastal State maritime
areas may be regulated under the Convention on
International Trade in Endangered Species of Flora
and Fauna (CITES) and under coastal and researching
State customs and import laws. The ownership of
data and samples in the researching State may
be regulated by private agreements between the
research oceanographer and the university or institution
where he or she is employed. Ownership over published
results is regulated by private employment agreements
and agreements with the publisher, stemming out
of copyright laws in the researching State. If
the results lead to innovations of a potentially
commercial nature, their ownership is regulated
by private employment agreements and other agreements
with funding agencies, whether the latter are
private industry, non-profit corporations or governments.
These agreements specify the distribution of benefits
arising from the commercialization of the products
or services derived from Research & Development
(R&D), including oceanographic research. Before
a product or process is commercialized, it is
subject to patent or other intellectual property
protection under domestic statutes and international
intellectual property treaties.
The rights that may accrue to coastal States
of origin of the commercialized samples are regulated
under the 1992 Convention on Biological Diversity
(CBD) and other private or bilateral agreements
between the coastal and the researching State.
The protection across international boundaries
of exclusive rights to use and sell certain information
or commercialized products, such as pharmaceuticals
derived from marine macro/micro-organisms, is
the subject of regulation under the General Agreement
on Tariffs and Trade (GATT), and may trigger the
application of relevant Trade Related Aspects
of Intellectual Property (TRIPS) Agreement provisions.
These regulatory regimes may give rise to domestic
disputes to be resolved by national judicial authorities,
or may be subject to settlement of disputes mechanisms
under UNCLOS, or may result in disputes of such
a global nature as to trigger dispute settlement
proceedings before the World Intellectual Property
Organization (WIPO) as well as the World Trade
Organization (WTO).
The following example illustrates how these regimes
can affect MSR. Under the 1982 UNCLOS, an oceanographer
seeking access into foreign coastal areas for
the purpose of collecting samples of live organisms
(i.e. marine flora and fauna) with potential medical
properties must first obtain clearance through
its Department of State or Foreign Affairs Ministry.
The diplomatic organ in the foreign coastal State
may grant clearance upon the condition that such
samples not be used for commercial purposes. UNCLOS
Arts. 241, 246.5, and 249.2 allow the coastal
State to block such development or to place significant
restrictions on the publication of results bearing
on its natural resources (i.e. live organisms
with potential economic value). But it can also
use these legal provisions to negotiate. Domestic
legislation and Art. 15 of the CBD may entitle
a coastal State to require that access be on mutually
beneficial terms. The coastal State is entitled
to negotiate for a share in the benefits deriving
from commercialized medical or pharmaceutical
products that use innovations derived from coastal
State marine organisms. Increasingly, the collection
of such organisms takes place under "letter of
collection" agreements, "material transfer" agreements,
or cooperative agreements between the coastal
State (or its qualified institution) and the oceanographer's
institution, pursuant to standards set out by
funding agencies in the State of the oceanographer
(its university or federal funding source). These
agreements aim to establish fair and equitable
arrangements for the protection of IPRs, set criteria
for the distribution of commercial benefits, and
provide continuity of international collaboration,
not least of which is continued access to raw
materials (where these may be required for clinical
tests leading to the commercial exploitation of
a pharmaceutical or other product).
Samples are then re-imported into the oceanographer's
country to be tested at the university laboratories.
Samples showing active components can be cultured
and the cultures may be deposited under the Budapest
Treaty on the Deposit of Microorganisms for Patent
Procedure, pending future application for patents
concerning new discoveries. If a new product or
process emerges as a result of the innovative
effort of the oceanographer (or his/her professional
colleagues), the oceanographer may proceed to
patent it. A patent grants the oceanographer (or
his or her institution) an exclusive right to
exploit the invention by taking out an exploitation
license. This may be achieved through a university's
own biotech "start-up" companies, or through independent
companies, including pharmaceutical and biotech
companies.
The ability to protect a patent internationally
is not automatic. It depends on the scope of membership
in international patent treaties and also on bilateral
or regional agreements. Membership in these treaties
or agreements is not compulsory. States may choose
not to become parties. However, TRIPS compels
States members of the WTO to implement and abide
by the system of international property rights
law. In this way, the sample obtained in a foreign
coastal State may make its way, albeit indirectly,
into the global trade arena in the form of an
anti-viral drug, or as an additive in an infant
formula nutritional supplement, or in a cosmetic.
[10] The oceanographer who collected the
sample becomes therefore a pawn in the complex
and fascinating chess-board of international trade.
Title Issues
Ownership of MSR data, samples and results is
shared among foreign oceanographers, researching
States, and coastal States of origin of the raw
materials. Determining their ownership shares
requires international lawyers and policy makers
to reconcile different principles of international
law relating to title. Central to this task is
a thorough understanding of UNCLOS Art. 241, according
to which MSR activities "shall not constitute
the legal basis for any claim to any part
of the marine environment or its resources"
(emphasis added). Arguably, intellectual property
claims would constitute a "claim" under Art.
241, and such claims would be subject to negotiation.
State practice indicates an increase in such negotiations.
Coastal States have also used UNCLOS Art. 249.2
to restrict the publication by foreign researchers
of MSR data, samples and results directly bearing
on coastal State natural resources and obtained
in coastal State waters.
[11] These articles have effects similar
to those of Art. 15, 1992 CBD, as they entitle
coastal States to negotiate the details over proprietary
claims to MSR data, samples and results obtained
by foreign oceanographers in coastal State waters.
Articles 10 (compilations of data), 39 (confidential
information/trade secrets) and 27 (patentable
subject-matter) of the TRIPS Agreement may also
have a considerable impact on certain MSR data,
samples and results.
Just as oceanographers did not welcome MSR regulation
under UNCLOS Part XIII, but generally have complied
with it in a satisfactory manner, Intellectual
Property Rights issues arising under the CBD and
TRIPS may cause initial concern, but are likely
to lead eventually to a mutually beneficial accommodation
between coastal and researching States' economic,
scientific, and intellectual property interests
over MSR data, samples and results. The UK study,
when published, should shed much needed light
in this area of international law if it examines
in depth the issues outlined above.
About the Author:
Montserrat Gorina-Ysern is an International Law
& Ocean Policy Consultant with extensive publications
in the field, including a book on maritime law
contracts (Editorial Bosch, Barcelona, 1984) and
her forthcoming book on An International Regime
for Marine Scientific Research (Transnational
Publishers, N.Y. 2003). Doctor Gorina-Ysern has
served as an adviser to the US Department of State,
the US Commission on Ocean Policy and is currently
an adviser to Conservation International on the
concept of a World Ocean Public Trust. She teaches
International Law & Legal Order at the School
of International Service, American University
in Washington, D.C.
[1] This article reproduces excerpts from Montserrat
Gorina-Ysern, AN INTERNATIONAL REGIME FOR MARINE
SCIENTIFIC RESEARCH, Transnational Publishers
(Forthcoming 2003) with the publisher's permission.
[2] Biotechnology refers to a range of techniques
for identifying, developing and using the properties
of "living things" to make products
or services. It selects "natural strains
of organisms that carry desirable traits, makes
hybrids by fusing cells from different parental
sources, uses chemicals and radiation to create
mutant strains, or genetically engineers plants,
animals, and microorganisms to produce specific
phenotypic characteristics." See Sean D.
Murphy, Biotechnology and International Law
42:1, 47-139 HARVARD INT'L. L.J. (2001) at 47;
see also GENOMES TO LIFE. ACCELERATING
BIOLOGICAL DISCOVERY (US Department of Energy,
Apr. 2001).
[3] PERSPECTIVES ON INTELLECTUAL PROPERTY (Peter Drahos
and Michael Blakeney eds.) 160 (2001).
[4] See Scripps Scientists Discover Rich Medical
Drug Resource in Deep Ocean Sediments Promising
cancer-fighting candidates emerge from tropical
ocean 'mud' at http://scrippsnews.ucsd.edu/article_detail.cfm?article_num=561;
see also Access to Drugs During Public Health
Crises, 2002 ABA ANNUAL MEETING (Washington,
D.C.) August 9, 2002.
[5] Opportunities for Environmental Applications of
Marine Biotechnology, NATIONAL RESEARCH COUNCIL
(Washington, D.C.) October 1999.
[6] Biliana Cicin-Sain, Robert W. Knecht, Lori Denno
Bouman, and Gregory W. Fisk, Emerging Policy
Issues in the Development of Marine Biotechnology,
12 OCEAN YEARBOOK 179 (1996).
[7] Lyne Glowka, The Deepest of Ironies: Genetic
Resources, Marine Scientific Research, and the
Area, 12 OCEAN YEARBOOK 96 (1996) at 160.
[9] Intergovernmental Oceanographic Commission (of
Unesco). Ocean Science for the Year 2000. Twelfth
Session of the Assembly, Paris, November 3-20
1982, reprinted in OCEAN YEARBOOK (1983).
[10] MARINE BIOTECHNOLOGY IN THE TWENTY-FIRST CENTURY:
PROBLEMS, PROMISE, AND PRODUCTS (National Academy
of Sciences, 2002). Table 1. Some Examples of
Commercially Available Marine Bioproducts.
[11] UNCLOS Art. 249.2 says, "This article
is without prejudice to the conditions established
by the laws and regulations of the coastal State
for the exercise of its discretion to grant
or withhold consent pursuant to Article 246,
paragraph 5, including requiring prior agreement
for making internationally available the research
results of a project of direct significance
for the exploration and exploitation of natural
resources."
_________________________________________________________________________
The purpose of ASIL Insights is to provide concise
and informed background for developments of
interest to the international community. The
American Society of International Law
does not take positions on substantive issues,
including the ones discussed in this Insight.
ASIL
Insights may be found on the ASIL
Web Site.
Educational copying is permitted with due acknowledgement.